| Death within 30 days | Survival within 30 days | p |
---|---|---|---|
Number (sample size) | 889 | 3670 | Â |
Baseline variables and in-hospital factors | |||
 Age (year, mean SD) | 71.42 ± 15.93 | 63.61 ± 17.73 | 8.95E−36 |
Sex (%) | |||
 Female | 413 | 1609 |  |
 Male | 476 | 2061 | 0.1706 |
Ethnicity (%) | |||
 White | 617 (69.4%) | 2642 (72.1%) |  |
 Black | 66 (7.4%) | 338 (9.2%) |  |
 Yellow | 34 (3.8%) | 145 (4%) |  |
 Others | 172 (19.3%) | 545 (14.9%) | 0.005914 |
 Weight (kg), mean (SD) | 76.91 ± 21.31 | 82.69 ± 28.61 |  |
 Height (cm), mean (SD) | 168.27 ± 11.66 | 169.51 ± 10.73 |  |
 BMI (kg/m2), mean (SD) | 27.82 ± 7.65 | 29.25 ± 8.91 |  |
 Length of stay in hospital, days, mean (SD) | 7.04 ± 6.3 | 10.99 ± 10.4 |  |
 Length of stay in the ICU, days, mean (SD) | 4.87 ± 4.99 | 4.66 ± 6.31 |  |
Admission type | |||
 MED | 580 (65.2%) | 1912 (52.1%) |  |
 CMED | 86 (9.7%) | 477 (13.0%) |  |
 Others | 223 (25.1%) | 1282 (34.9%) | 1.36E−11 |
Vital signs | |||
 Heartrate_min (times/min), mean (SD) | 72.92 ± 19.16 | 73.08 ± 15.72 | 0.826205355 |
 Heartrate_mean (times/min), mean (SD) | 91.12 ± 18.27 | 87.81 ± 16.15 | 0.00000579 |
 Sysbp_min (mmhg), mean (SD) | 80.46 ± 20.01 | 90.69 ± 16.18 | 6.49E−36 |
 Diasbp_mean (mmhg), mean (SD) | 58.65 ± 10.42 | 61.7 ± 10.08 | 6.62E−13 |
 Meanbp_min (mmhg), mean (SD) | 48.41 ± 15.65 | 56.24 ± 13.89 | 6.74E−34 |
 Resprate_mean (times/min),mean (SD) | 21.73 ± 4.68 | 19.54 ± 4.06 | 3.66E−30 |
 Tempc_min (℃), mean (SD) | 35.77 ± 1.17 | 36.15 ± 0.86 | 1.78E−16 |
 Tempc_max (℃), mean (SD) | 37.34 ± 1.17 | 37.65 ± 0.85 | 3.37E−11 |
 Spo2_mean (%), mean (SD) | 96.03 ± 4.02 | 97.1 ± 1.96 | 3.06E−12 |
Laboratory parameters | |||
 Aniongap_max (mmhg), mean (SD) | 19.12 ± 6.26 | 16.17 ± 4.65 | 1.45E−31 |
 Aniongap_min (mmhg), mean (SD) | 14.58 ± 4.66 | 12.45 ± 3.08 | 1.48E−30 |
 Creatinine_min (ng/dL), mean (SD) | 1.65 ± 1.23 | 1.35 ± 1.39 | 3.89E−09 |
 Chloride_min (mmol/L), mean (SD) | 101.67 ± 7.65 | 101.93 ± 6.69 | 0.39868745 |
 Hemoglobin_min (g/dL), mean (SD) | 9.84 ± 2.21 | 10.08 ± 2.08 | 0.009534544 |
 Hemoglobin_max, (g/dL), mean (SD) | 11.77 ± 2.26 | 12 ± 2.09 | 0.012634047 |
 Lactate_min (mmol/L), mean (SD) | 2.36 ± 2.07 | 1.55 ± 0.81 | 4.26E−24 |
 Platelet_min (109/L), mean (SD) | 189.73 ± 125.29 | 195.98 ± 108.29 | 0.207608419 |
 Potassium_min (mmol/L), mean (SD) | 3.84 ± 0.7 | 3.71 ± 0.54 | 0.00000328 |
 Sodium_min (mmol/L), mean (SD) | 136.27 ± 6.62 | 136.08 ± 5.35 | 0.454879474 |
 Sodium_max (mmol/L), mean (SD) | 141.28 ± 6.8 | 140.51 ± 5.03 | 0.003570629 |
 Bun_min (mmol/L), mean (SD) | 36.09 ± 25.43 | 24.22 ± 19.69 | 8.45E−31 |
 Bun_max (mmol/L), mean (SD) | 42.88 ± 28.49 | 30.23 ± 24.39 | 1.12E−27 |
 Wbc_min (109/L), mean (SD) | 12.54 ± 12.22 | 10.41 ± 6.55 | 4.81E−06 |
 Wbc_max (109/L), mean (SD) | 17.54 ± 19.99 | 14.8 ± 9.87 | 0.000293182 |
 Inr_max, mean (SD) | 2.12 ± 1.79 | 1.61 ± 1.34 | 2.89E−14 |
 Urine output | 1225.29 ± 1307.53 | 1993.04 ± 1551.57 | 2.82E−48 |
Score system | |||
 SOFA | 8.02 ± 4.33 | 5.22 ± 2.85 | 2.74E−55 |
 qSOFA | 2.15 ± 0.64 | 1.9 ± 0.69 | 4.60E−21 |
 SAPS II | 54.67 ± 16.37 | 37.51 ± 13.22 | 2.2E−16 |
Advanced life support | |||
 Mechanical ventilation | 531 (59.69%) | 1668 (45.55%) |  |
 Renal replacement therapy | 53 (5.95%) | 135 (3.61%) | 0.2503 |
Accompanied diseases (comorbidity) | |||
 Diabetes | 246 (27.64%) | 2631 (71.70%) |  |
 Malignant tumour | 116 (13.05%) | 160 (4.37%) |  |
 Others | 527 (59.31%) | 879 (23.93%) | 2.20E−16 |
Common sources of infection | |||
 Blood culture | 418 (47%) | 1343 (36.6%) |  |
 MRSA screen | 267 (30%) | 1384 (37.72%) |  |
 Urine | 151 (17%) | 642 (17.5%) |  |
 Swab | 18 (2%) | 70 (1.9%) |  |
 Others | 35 (4%) | 231 (6.3%) | 7.82E−08 |
Outcome | |||
 Within 30-days mortality | 19.50% | 80.50% |  |